"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

copy info icon

Key data

Status

Active

KRS number

0000092404copy info icon

REGON

01190140100000copy info icon

NIP/VAT code

5271113612copy info icon

VAT registration date

01/07/1996

VAT status

Active

Bankruptcy proceedings

No proceedings

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

Registered address

UL. KRAKOWIAKÓW 46, 02-255, WARSZAWA, POLSKAcopy info icon
See on map
Website

Website

-
A Pie Chart

A

Highest
Highest reliabilityLowest reliability

Reliability

Selected TriangleA - Highest
B - High
C - Average
D - Low
E - Lowest

Incorporation date

18/02/2002

Share capital

9,021,000.00 PLN

Primary activity

Research and experimental development on biotechnology

Representatives

3

Representatives rights

DO REPREZENTACJI SPÓŁKI UPRAWNIONYCH JEST DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM

Representatives

dot
Member of the management boardJ*** V******* G*****-E****
dot
Member of the management boardK******** M********* K********
dot
Member of the management boardR***** J******

Business linkages

Price: €14.99 (without VAT)
Premium users: 1.00 credit

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit

People

Representatives

3
Personsort default icon
Titlesort default icon
J*** V******* G*****-E****
Member of the management board
K******** M********* K********
Member of the management board
R***** J******
Member of the management board

Persons with Significant Control

1
psc login icon

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

€

Net Profit (zł)

47,369,254

Net Profit (zł)

47,369,254

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit
Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%)info
Liquidity ratioinfo
Net profitability (%)info
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)
2022
234,179,491
13,752,485
9,660,912
0.20
2.01
4.13
41,479,289
46,390,928
0
2,134,682
2023
327,143,263
20,259,236
14,888,626
0.22
2.15
4.55
56,367,915
63,509,497
0
2,390,697
2024
413,995,330
24,635,041
47,369,254
0.31
2.90
11.44
103,737,169
67,115,378
0
-
2024
413,995,330
24,635,041
47,369,254
0.31
2.90
11.44
103,737,169
67,115,378
0
-

2024

Turnover (zł)

413,995,330 złAscended27 % *

Profit before tax (zł)

24,635,041 złAscended22 % *

Net Profit (zł)

47,369,254 złAscended218 % *

Working capital requirement (%)

0.31 Ascended40.91 % *

Liquidity ratio

2.90 Ascended34.88 % *

Net profitability (%)

11.44 %Ascended151.43 % *

Equity (zł)

103,737,169 złAscended84 % *

Current liabilities (zł)

67,115,378 złAscended6 % *

Non current liabilities (zł)

0 złAscended- *

Non-current Assets (zł)

-
*over the last year starting selected period

Credit history

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

Credit report

Price: 1.00 credit
Unpaid debts
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Debt typesort default icon
-
-
-
-
Debt payment history
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Payment datesort default icon
Debt typesort default icon
-
-
-
-
-

Documents

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

24
Datesort default icon
Descriptionsort default icon
12/06/2025
OD 01.01.2024 DO 31.12.2024
26/06/2024
OD 01.01.2023 DO 31.12.2023
06/06/2023
OD 01.01.2022 DO 31.12.2022
31/08/2022
OD 01.01.2021 DO 31.12.2021
01/07/2021
OD 01.01.2020 DO 31.12.2020